Require visibility into the order lifecycle and classify each data relationship correctly. A pharmacy receiving information for treatment is not automatically a business associate simply because it receives patient information. HHS expressly distinguishes treatment disclosures from business-associate arrangements, while recognizing that another service relationship can create different obligations. (hhs.gov)
Proposed integration checklist:
- Accepted, rejected, clarification-needed, payment-pending, shipped, delivered and cancelled statuses.
- Reliable patient/order matching and duplicate prevention.
- Human-readable failure reasons.
- Audit logs, access controls and incident escalation.
- Subcontractor disclosure and role mapping.
- Exportable records and transition support.
- Restrictions on secondary use, marketing and model training appropriate to the arrangement.
Where a business-associate agreement is required, HHS’s sample provisions address permitted uses, safeguards, subcontractors, reporting and termination-related handling of information. (hhs.gov)
Test the workflow with approved synthetic cases before a controlled patient pilot. Keep patient-identifiable data out of public procurement calculators and research uploads.
Sources cited on this page
- hhs.gov · Source 1 ↗https://www.hhs.gov/hipaa/for-professionals/faq/do-i-need-a-business-associate-contract-to-disclose-information-to-a-provider/index.html?utm_source=openai
- hhs.gov · Source 2 ↗https://www.hhs.gov/hipaa/for-professionals/covered-entities/sample-business-associate-agreement-provisions/index.html?utm_source=openai